Pfizer announced Tuesday that it is seeking emergency use authorization from the US Food and Drug Administration for its experimental antiviral Covid-19 pill, known as PF-07321332 or Paxlovid. Once it gets the authorization, our strength in this battle against COVID will be much stronger!
Photo Credit: Anna Shvets